How Ozempic Became a Celebrity Weight Loss Sensation

TikTook influencers are sharing how a lot weight they misplaced utilizing Ozempic, an costly sort 2 diabetes drug, even when they don’t have diabetes. This has led to a surge in demand amongst these prepared to pay the excessive out-of-pocket value – resulting in a international scarcity.
For many individuals with sort 2 diabetes, Ozempic, or semaglutide, is a vital treatment that helps them handle their blood glucose and stop harmful issues. However, one of many drug’s important uncomfortable side effects, weight lack of round 14.9%, has prompted many individuals who should not have diabetes to take the drug for its weight reduction results. 
In a viral pattern referred to as #Ozempic and #OzempicProblem, customers of the social media app TikTook are sharing their spectacular weight reduction outcomes after utilizing Ozempic. This resulted in additional than 250 million views on the platform and endorsements from standard influencers. That led to a surge in use and the FDA designating the treatment as “Currently in Shortage.” Novo Nordisk has cited each elevated demand and provide chain points at certainly one of its manufacturing services as causes for this scarcity.
How did Ozempic develop into standard for weight reduction?

Touted as a game-changer for the weight problems epidemic, Ozempic is much like a hormone referred to as GLP-1, which regulates urge for food, inflicting folks to really feel full sooner and eat fewer energy. Ozempic’s weight reduction properties first made headlines in 2021 when the drug was featured on The Dr. Oz Show in a section titled, “Could a Diabetes Drug Cure Obesity?”
Novo Nordisk, the drug’s producer, obtained Ozempic’s approval for diabetes therapy in December 2017. Subsequently, a greater dosage of Ozempic’s lively ingredient, semaglutide 2.4mg, was accredited for weight reduction in June 2021 and branded as Wegovy. On October 1st of this 12 months, Tesla CEO and proprietor of Twitter Elon Musk tweeted that the key to his weight reduction was “fasting and Wegovy,” fueling higher curiosity within the drug. However, because of a scarcity of Wegovy, healthcare suppliers started prescribing Ozempic to these searching for weight reduction.
Additionally, the price of Wegovy earlier than insurance coverage is round $1,400 a month, considerably greater than Ozempic’s out-of-pocket fee of roughly $900 a month. Since insurance coverage usually doesn’t cowl prescriptions for weight reduction, some have seen Ozempic as a extra reasonably priced choice that results in important weight reduction. 
What are the results for folks with diabetes?
The surge in curiosity in Ozempic has led to a scarcity of the drug across the nation, forcing many individuals with diabetes to change to options. 
Unfortunately, substitute medicine for Ozempic (that’s, different GLP-1 medicine) could not have the identical protection by insurance coverage firms, and there could also be further restrictions to entry the substitutes. 
For those that are struggling to acquire Ozempic, converse to your healthcare supplier to debate different GLP-1 medicines, comparable to Victoza and Trulicity. Victoza is a once-daily injection, and Trulicity is a once-weekly injection. Additionally, a newer treatment referred to as Mounjaro (tirzepatide) has been proven to supply spectacular reductions in A1C and weight. Tirzepatide is at present in scientific trials for weight reduction and might be submitted for FDA approval for weight reduction subsequent 12 months. 
However, it will not be any simpler to fill a prescription for that product. While Eli Lilly does promise an elevated provide of Mounjaro subsequent 12 months, it is going to nearly definitely be the subsequent goal for these searching for weight reduction drugs.
To study extra about Ozempic, Wegovy, and Mounjaro, see our different articles:



What do you suppose?

Do you suggest this text?

Subscribe to our weekly publication & get extra articles like this one

About the authors

Arvind Sommi joined the diaTribe Foundation in 2021 after graduating from the University of Florida with a diploma in Biology. Sommi is an Editor for diaTribe Learn. Arvind Sommi joined…
Read the total bio »

Recommended For You